Patents Assigned to PATHWAY GENOMICS CORPORATION
  • Patent number: 10733903
    Abstract: In accordance with the present invention, there are provided health and wellness management methods which generate an action plan set of recommendations by taking into account a wide variety of inputs, including subject-specific information and globally applicable information. Also provided herewith are systems for the practice of the above-described methods.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: August 4, 2020
    Assignee: Pathway Genomics Corporation
    Inventors: Scott J. Kurowski, Michael P. Nova
  • Publication number: 20160071432
    Abstract: In accordance with the present invention, there are provided health and wellness management methods which generate an action plan set of recommendations by taking into account a wide variety of inputs, including subject-specific information and globally applicable information. Also provided herewith are systems for the practice of the above-described methods.
    Type: Application
    Filed: August 18, 2015
    Publication date: March 10, 2016
    Applicant: PATHWAY GENOMICS CORPORATION
    Inventors: Scott J. Kurowski, Michael P. Nova
  • Publication number: 20150292014
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.
    Type: Application
    Filed: March 12, 2014
    Publication date: October 15, 2015
    Applicant: Pathway Genomics Corporation
    Inventors: Guangdan Zhu, Cindy Wang, Tanya Moreno, Andrew Hellman, Alok Tomar, Svetlana Ivanova Gramatikova, Aditi Chawla, Russell Kuo-fu Chan, Andria Del Tredici, Adrian Vilalta, K. David Becker, Michael Nova
  • Patent number: 9128057
    Abstract: Dual mode genetics testing systems are devised about a single element testing platform. A microfluidic network and system of interconnected receiving cells and reaction vessels supports at the same time genotyping and copy number analysis where the platform may be subject to a common thermal cycle schedule to cause the proper reactions (DNA replication) necessary in both test types. Further, the microfluidic platform which includes reaction vessels for genotyping which are spatially removed from reaction vessels for copy number analysis, is coupled to optical scanner and detection systems specifically arranged to apply test specific detection routines on each of these distinct regions or portions of the dual mode test platform.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 8, 2015
    Assignee: Pathway Genomics Corporation
    Inventors: Tanya Moreno, Cindy Wang, David Becker
  • Patent number: 8932539
    Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 13, 2015
    Assignee: Pathway Genomics Corporation
    Inventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
  • Publication number: 20140272950
    Abstract: The present inventions relates to methods and assays to predict the response of an individual to an SSRI treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a selective serotonin reuptake inhibitor (SSRI).
    Type: Application
    Filed: June 13, 2013
    Publication date: September 18, 2014
    Applicant: Pathway Genomics Corporation
    Inventors: Cindy Wang, Tanya Moreno, K. David Becker
  • Publication number: 20140205516
    Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 24, 2014
    Applicant: PATHWAY GENOMICS CORPORATION
    Inventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
  • Patent number: D790726
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: June 27, 2017
    Assignee: Pathway Genomics Corporation
    Inventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliot